Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (141-150 of 999) with videos related to

Pageof 100
Sort By:
Pharmacogenetics|May 7, 2004
Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis studySuetnee Chen, Natalia Tsybouleva, Christie M Ballantyne, et al.
Journal of Clinical Lipidology|October 16, 2018
Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponseAnum Saeed, Salim S Virani, Peter H Jones, et al.
Circulation|February 18, 2020
The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular RiskAnandita Agarwala, Erin D Michos, Zainab Samad, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 19, 2002
Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatinLorraine Salek, Silvia Lutucuta, Christie M Ballantyne, et al.
Circulation Research|March 4, 2000
A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosisC Cahilly, C M Ballantyne, D S Lim, et al.
Journal of Studies on Alcohol and Drugs|June 15, 2007
Interaction effects of high-density lipoprotein metabolism gene variation and alcohol consumption on coronary heart disease risk: the atherosclerosis risk in communities studyKelly Volcik, Christie M Ballantyne, Henry J Pownall, et al.
Journal of the American College of Cardiology|January 28, 2012
Chronic hyperglycemia and subclinical myocardial injuryJonathan Rubin, Kunihiro Matsushita, Christie M Ballantyne, et al.
Current Atherosclerosis Reports|April 8, 2004
Cardiovascular implications of HIV-associated dyslipidemic lipodystrophyRajagopal V Sekhar, Farook Jahoor, Henry J Pownall, et al.
American Journal of Epidemiology|April 10, 2009
Using the whole cohort in the analysis of case-cohort dataNorman E Breslow, Thomas Lumley, Christie M Ballantyne, et al.
Atherosclerosis|April 11, 2007
Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) studyKelly A Volcik, Christie M Ballantyne, Josef Coresh, et al.
Pageof 100

Showing results (141-150 of 999) with videos related to

Sort By:
Pageof 100
Pharmacogenetics|May 7, 2004
Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis studySuetnee Chen, Natalia Tsybouleva, Christie M Ballantyne, et al.
Journal of Clinical Lipidology|October 16, 2018
Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponseAnum Saeed, Salim S Virani, Peter H Jones, et al.
Circulation|February 18, 2020
The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular RiskAnandita Agarwala, Erin D Michos, Zainab Samad, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 19, 2002
Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatinLorraine Salek, Silvia Lutucuta, Christie M Ballantyne, et al.
Circulation Research|March 4, 2000
A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosisC Cahilly, C M Ballantyne, D S Lim, et al.
Journal of Studies on Alcohol and Drugs|June 15, 2007
Interaction effects of high-density lipoprotein metabolism gene variation and alcohol consumption on coronary heart disease risk: the atherosclerosis risk in communities studyKelly Volcik, Christie M Ballantyne, Henry J Pownall, et al.
Journal of the American College of Cardiology|January 28, 2012
Chronic hyperglycemia and subclinical myocardial injuryJonathan Rubin, Kunihiro Matsushita, Christie M Ballantyne, et al.
Current Atherosclerosis Reports|April 8, 2004
Cardiovascular implications of HIV-associated dyslipidemic lipodystrophyRajagopal V Sekhar, Farook Jahoor, Henry J Pownall, et al.
American Journal of Epidemiology|April 10, 2009
Using the whole cohort in the analysis of case-cohort dataNorman E Breslow, Thomas Lumley, Christie M Ballantyne, et al.
Atherosclerosis|April 11, 2007
Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) studyKelly A Volcik, Christie M Ballantyne, Josef Coresh, et al.
Pageof 100